Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data (Q34327932)
scientific article
Language:
(P31) (Q13442814)
(P275) (Q18810331)
(P304) 313-321
(P407) (Q1860)
(P478) 8
(P577) Wednesday, June 20, 2012
(P921) (Q8277)
(P1433) (Q15766913)
(P1476) "Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data" (language: en)
(P2093) Gary Bloomgren
Bjørn Sperling
Kimberly Cushing
Madé Wenten
(P2860) (Q33870816)
(Q33576469)
(Q28299151)
(Q36064845)
(Q34511062)
(Q34375520)
(Q48655922)
(Q39458420)
(Q44090438)
(Q44102121)
(Q45366097)
(Q43512635)
(Q50564290)
(Q57697732)
(Q71534203)
(Q80464860)
(Q71604516)
(Q84773927)
(Q83367293)
(P6216) (Q50423863)
other details
description scientific article

External Links